Literature DB >> 22364545

Bioluminescence methodology for the detection of protein-protein interactions within the voltage-gated sodium channel macromolecular complex.

Alexander Shavkunov1, Neli Panova, Anesh Prasai, Ron Veselenak, Nigel Bourne, Svetla Stoilova-McPhie, Fernanda Laezza.   

Abstract

Protein-protein interactions are critical molecular determinants of ion channel function and emerging targets for pharmacological interventions. Yet, current methodologies for the rapid detection of ion channel macromolecular complexes are still lacking. In this study we have adapted a split-luciferase complementation assay (LCA) for detecting the assembly of the voltage-gated Na+ (Nav) channel C-tail and the intracellular fibroblast growth factor 14 (FGF14), a functionally relevant component of the Nav channelosome that controls gating and targeting of Nav channels through direct interaction with the channel C-tail. In the LCA, two complementary N-terminus and C-terminus fragments of the firefly luciferase were fused, respectively, to a chimera of the CD4 transmembrane segment and the C-tail of Nav1.6 channel (CD4-Nav1.6-NLuc) or FGF14 (CLuc-FGF14). Co-expression of CLuc-FGF14 and CD4-Nav1.6-NLuc in live cells led to a robust assembly of the FGF14:Nav1.6 C-tail complex, which was attenuated by introducing single-point mutations at the predicted FGF14:Nav channel interface. To evaluate the dynamic regulation of the FGF14:Nav1.6 C-tail complex by signaling pathways, we investigated the effect of kinase inhibitors on the complex formation. Through a platform of counter screenings, we show that the p38/MAPK inhibitor, PD169316, and the IκB kinase inhibitor, BAY 11-7082, reduce the FGF14:Nav1.6 C-tail complementation, highlighting a potential role of the p38MAPK and the IκB/NFκB pathways in controlling neuronal excitability through protein-protein interactions. We envision the methodology presented here as a new valuable tool to allow functional evaluations of protein-channel complexes toward probe development and drug discovery targeting ion channels implicated in human disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364545      PMCID: PMC3362325          DOI: 10.1089/adt.2011.413

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  84 in total

1.  The penultimate rotamer library.

Authors:  S C Lovell; J M Word; J S Richardson; D C Richardson
Journal:  Proteins       Date:  2000-08-15

Review 2.  Protein misfolding, aggregation, and degradation in disease.

Authors:  Niels Gregersen; Lars Bolund; Peter Bross
Journal:  Methods Mol Biol       Date:  2003

3.  Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis.

Authors:  Chang-Deng Hu; Tom K Kerppola
Journal:  Nat Biotechnol       Date:  2003-04-14       Impact factor: 54.908

Review 4.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

5.  Impaired hippocampal synaptic transmission and plasticity in mice lacking fibroblast growth factor 14.

Authors:  Maolei Xiao; Lin Xu; Fernanda Laezza; Kelvin Yamada; Sheng Feng; David M Ornitz
Journal:  Mol Cell Neurosci       Date:  2007-01-08       Impact factor: 4.314

6.  Role of axonal NaV1.6 sodium channels in action potential initiation of CA1 pyramidal neurons.

Authors:  Michel Royeck; Marie-Therese Horstmann; Stefan Remy; Margit Reitze; Yoel Yaari; Heinz Beck
Journal:  J Neurophysiol       Date:  2008-07-23       Impact factor: 2.714

7.  Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): A new phenotype.

Authors:  Esther Brusse; Inge de Koning; Anneke Maat-Kievit; Ben A Oostra; Peter Heutink; John C van Swieten
Journal:  Mov Disord       Date:  2006-03       Impact factor: 10.338

8.  Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels.

Authors:  Jun-Yang Lou; Fernanda Laezza; Benjamin R Gerber; Maolei Xiao; Kathryn A Yamada; Hali Hartmann; Ann Marie Craig; Jeanne M Nerbonne; David M Ornitz
Journal:  J Physiol       Date:  2005-09-15       Impact factor: 5.182

9.  FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons.

Authors:  Vikram G Shakkottai; Maolei Xiao; Lin Xu; Michael Wong; Jeanne M Nerbonne; David M Ornitz; Kelvin A Yamada
Journal:  Neurobiol Dis       Date:  2008-10-01       Impact factor: 5.996

10.  Grand challenge for ion channels: an underexploited resource for therapeutics.

Authors:  Diana Conte Camerino; Jean-François Desaphy
Journal:  Front Pharmacol       Date:  2010-08-20       Impact factor: 5.810

View more
  30 in total

1.  CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability.

Authors:  Wei-Chun J Hsu; Federico Scala; Miroslav N Nenov; Norelle C Wildburger; Hannah Elferink; Aditya K Singh; Charles B Chesson; Tetyana Buzhdygan; Maveen Sohail; Alexander S Shavkunov; Neli I Panova; Carol L Nilsson; Jai S Rudra; Cheryl F Lichti; Fernanda Laezza
Journal:  FASEB J       Date:  2016-02-25       Impact factor: 5.191

2.  PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Wei-Chun J Hsu; Norelle C Wildburger; Sigmund J Haidacher; Miroslav N Nenov; Oluwarotimi Folorunso; Aditya K Singh; Brent C Chesson; Whitney F Franklin; Ibdanelo Cortez; Rovshan G Sadygov; Kelly T Dineley; Jay S Rudra; Giulio Taglialatela; Cheryl F Lichti; Larry Denner; Fernanda Laezza
Journal:  Exp Neurol       Date:  2017-05-15       Impact factor: 5.330

3.  The fibroblast growth factor 14·voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3).

Authors:  Alexander S Shavkunov; Norelle C Wildburger; Miroslav N Nenov; Thomas F James; Tetyana P Buzhdygan; Neli I Panova-Elektronova; Thomas A Green; Ronald L Veselenak; Nigel Bourne; Fernanda Laezza
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

Review 4.  Integrative biological analysis for neuropsychopharmacology.

Authors:  Mark R Emmett; Roger A Kroes; Joseph R Moskal; Charles A Conrad; Waldemar Priebe; Fernanda Laezza; Anke Meyer-Baese; Carol L Nilsson
Journal:  Neuropsychopharmacology       Date:  2013-06-26       Impact factor: 7.853

5.  Identification of peptidomimetics as novel chemical probes modulating fibroblast growth factor 14 (FGF14) and voltage-gated sodium channel 1.6 (Nav1.6) protein-protein interactions.

Authors:  Zhiqing Liu; Paul Wadsworth; Aditya K Singh; Haiying Chen; Pingyuan Wang; Oluwarotimi Folorunso; Pietro Scaduto; Syed R Ali; Fernanda Laezza; Jia Zhou
Journal:  Bioorg Med Chem Lett       Date:  2018-12-15       Impact factor: 2.823

Review 6.  Voltage-gated sodium currents in cerebellar Purkinje neurons: functional and molecular diversity.

Authors:  Joseph L Ransdell; Jeanne M Nerbonne
Journal:  Cell Mol Life Sci       Date:  2018-07-07       Impact factor: 9.261

7.  Fibroblast Growth Factor 14 Modulates the Neurogenesis of Granule Neurons in the Adult Dentate Gyrus.

Authors:  Musaad A Alshammari; Tahani K Alshammari; Miroslav N Nenov; Federico Scala; Fernanda Laezza
Journal:  Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.590

8.  Modulation of the FGF14:FGF14 homodimer interaction through short peptide fragments.

Authors:  Syed Ali; Alexander Shavkunov; Neli Panova; Svetla Stoilova-McPhie; Fernanda Laezza
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

9.  Protein-Protein Interactions as New Targets for Ion Channel Drug Discovery.

Authors:  Svetla Stoilova-McPhie; Syed Ali; Fernanda Laezza
Journal:  Austin J Pharmacol Ther       Date:  2013-12-31

10.  Identification of Amino Acid Residues in Fibroblast Growth Factor 14 (FGF14) Required for Structure-Function Interactions with Voltage-gated Sodium Channel Nav1.6.

Authors:  Syed R Ali; Aditya K Singh; Fernanda Laezza
Journal:  J Biol Chem       Date:  2016-03-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.